PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2671144

Vancomycin. A new old agent.

M J Ingerman·J Santoro
View original source ↗Export metadata ↓

Abstract

Interest in vancomycin has been rekindled by the emergence of resistant gram-positive pathogens and the improvement in drug purity. The antimicrobial activity, pharmacokinetics, clinical indications, dosing schedules, and adverse reactions of vancomycin are summarized.

Explore related subjects

Bacterial InfectionsGram-Positive BacteriaVancomycinJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M J Ingerman, J Santoro. 1989. Vancomycin. A new old agent.. https://pubmed.ncbi.nlm.nih.gov/2671144/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

[Infections in intensive care units. A challenge for the specialist of infectious diseases?].

There is an obvious need for teamwork between different specialists on the diagnosis and treatment of patients in an intensive care unit. The infectious disease specialist must contribute by establishing definite and quick diagnosis of infections and by employing an adequate and sensible antibiotic policy for successful treatment. The local microbiological flora should be kept at an acceptable level of resistance to antibiotics, and preventive measures should be chosen carefully. To achieve this goal, extensive knowledge on antibiotics and microbial epidemiology is essential.

Bacterial Infections↗